Literature DB >> 19325208

Immunohistochemical expression of PCNA, p53, bax and bcl-2 in oral lichen planus and epithelial dysplasia.

Fernando A C G de Sousa1, Thaís C Paradella, Yasmin R Carvalho, Luiz E B Rosa.   

Abstract

The potential for malignant transformation of oral lichen planus is still controversial. The expression of proteins related to cell proliferation and apoptosis in oral lichen planus and epithelial dysplasia was analyzed to evaluate the true potential for malignant transformation of this disease. Twenty-four cases of each lesion were subjected to the streptoavidin-biotin technique for identifying the immunohistochemical expression of PCNA, p53, bax, and bcl-2 proteins. Of the 24 cases of oral lichen planus, 14 (58.33%) were positive for PCNA, 10 (41.67%) for p53, 4 (16.67%) for bcl-2 and 12 (50%) for bax, whereas of the 24 cases of epithelial dysplasia, 20 (83.33%) were positive for PCNA, 10 (41.67%) for p53, 6 (25%) for bcl-2, and 20 (83.33%) for bax. Chi-squared test showed no statistically significant differences between the expression of p53 and bcl-2 in oral lichen planus and epithelial dysplasia, regardless of the grade (P > 0.05). However, the expression of PCNA and bax was significantly increased in epithelial dysplasia (P < 0.05). The results of this study showed that alterations in expression of these proteins are observed in oral lichen planus and epithelial dysplasia, suggesting the potential for malignant transformation in both lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325208     DOI: 10.2334/josnusd.51.117

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  14 in total

Review 1.  Oral lichenoid lesions: distinguishing the benign from the deadly.

Authors:  Susan Müller
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

2.  Myeloid cell leukemia-1 is a molecular indicator for malignant transformation of oral lichen planus.

Authors:  Ji-Ae Shin; Jae-Min Seo; Sejun Oh; Sung-Dae Cho; Kyung-Eun Lee
Journal:  Oncol Lett       Date:  2016-01-08       Impact factor: 2.967

3.  Clinicopathological correlation of Bcl-2 oncoprotein expression in oral precancer and cancer.

Authors:  Vandana Arya; Subash Singh; M Jonathan Daniel
Journal:  J Oral Biol Craniofac Res       Date:  2016-01-19

4.  Expression of Ki-67, p53, α-SMA and COX-2 in lichen planus and related lesions: A pilot study.

Authors:  D S Sanketh; Karuna Kumari; Roopa S Rao; Vanishree C Haragannavar; Sachin C Sarode; Gargi S Sarode; A Thirumal Raj; Shankargouda Patil
Journal:  J Oral Biol Craniofac Res       Date:  2018-02-19

Review 5.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

Review 6.  Oral lichen planus as a preneoplastic inflammatory model.

Authors:  Eleni A Georgakopoulou; Marina D Achtari; Michael Achtaris; Periklis G Foukas; Athanassios Kotsinas
Journal:  J Biomed Biotechnol       Date:  2012-05-17

7.  Estimation of malignant transformation rate in cases of oral epithelial dysplasia and lichen planus using immunohistochemical expression of Ki-67, p53, BCL-2, and BAX markers.

Authors:  G Shailaja; J Vijay Kumar; P V Baghirath; U Kumar; G Ashalata; A Bhargavi Krishna
Journal:  Dent Res J (Isfahan)       Date:  2015 May-Jun

Review 8.  Apoptosis in immune-mediated diseases.

Authors:  S Leena Sankari; N Aravindha Babu; E Rajesh; M Kasthuri
Journal:  J Pharm Bioallied Sci       Date:  2015-04

9.  Assessment of bax and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.

Authors:  Shima Nafarzadeh; Sina Jafari; Ali Bijani
Journal:  Int J Mol Cell Med       Date:  2013

10.  Comparative analysis of cell proliferation ratio in plaque and erosive oral lichen planus: An immunohistochemical study.

Authors:  C Pramod Redder; Siddharth Pandit; Dinkar Desai; V Suresh Kandagal; Pramod S Ingaleshwar; Sharan J Shetty; Nupura Vibhute
Journal:  Dent Res J (Isfahan)       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.